RSN Letters to Regulatory Agencies

Click title text below to read each PDF:

December 6, 2021: Patient Access to and Adequate Reimbursement for Innovative ESRD Treatment

August 26, 2021: 2 RSN’s Response Letter to CMS Regarding Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System and Quality Initiative Program (QIP)

August 17, 2021: RSN’s Response Letter to FDA Regarding New Drug Application

April 6, 2020: RSN Responds to HHS Rule that will allow people who have ESRD to join Managed Care Programs in 2021

February 21, 2020: RSN Founder and President Lori Hartwell sends letter to Secretary Azar and Administrator Verma regarding CMS–3380–P: Medicare and Medicaid Programs; Organ Procurement Organizations Conditions for Coverage: Revisions to the Outcome Measure Requirements for Organ Procurement Organization

September 16, 2019: RSN Founder and President Lori Hartwell sends letter to Secretary Azar and Administrator Verma regarding the Medicare Program: Specialty Care Models to Improve Quality of Care and Reduce Expenditures directed from the Executive Order on Advancing Kidney Health

 

 

 

 

Web Id 8016